7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors

Details for Australian Patent Application No. 2010246608 (hide)

Owner Janssen Pharmaceuticals, Inc. Addex Pharma S.A.

Inventors Cid-Nunez, Jose Maria; De Lucas Olivares, Ana Isabel; Trabanco-Suarez, Andres Avelino; Macdonald, Gregor James

Agent FB Rice

Pub. Number AU-B-2010246608

PCT Pub. Number WO2010/130423

Priority 09160064.3 12.05.09 EP

Filing date 11 May 2010

Wipo publication date 18 November 2010

Acceptance publication date 11 October 2012

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437

A61K 31/444

A61K 31/445 - Non-condensed piperidines, e.g. piperocaine

A61P 25/00 Drugs for disorders of the nervous system

Event Publications

17 November 2011 PCT application entered the National Phase

  PCT publication WO2010/130423 Priority application(s): WO2010/130423

11 October 2012 Application Accepted

  Published as AU-B-2010246608

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010246609-1,2,4-triazolo [4,3-a] pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders

2010246607-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors